Trellus Health secures loan from major shareholder
The healthcare company has entered into a loan agreement with a major shareholder to support its commercial strategy and extend its near-term cash runway.
The healthcare company has entered into a loan agreement with a major shareholder to support its commercial strategy and extend its near-term cash runway.
The healthcare company has signed a 12-month contract with a leading global clinical research organization to utilize its Trellus TrialSet offering, further validating its strategic focus on the clinical trials sector.
The healthcare company has signed a 12-month contract with a leading global CRO to support recruitment and enrolment optimization for a clinical trial, leveraging its proprietary Trellus TrialSet™ program.
The healthcare company updates on its cash position, contract negotiations, and fundraising discussions.
The digital health solutions provider reported improved H1 results but faces critical funding challenges. With a cash runway extending only to November, the company is urgently exploring fundraising options to sustain operations.
The digital health platform provider reports revenue growth and new partnerships, but faces critical cash constraints. A fundraising effort is planned to extend operations beyond November 2025.
The healthcare company will report its interim results for the period ended 30 June 2025 on September 8th.
The healthcare technology company has announced a change in shareholding, with Dowgate Group Limited reducing its stake in the business.
The healthcare company provides an update on its focus areas and cost management efforts ahead of its AGM.
The healthcare company provides details on its upcoming Annual General Meeting.